Skip to main content

CTOS 2023 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Ming Tsao, MD, FRCPC

Princess Margaret Cancer Centre
Toronto, Ontario, Canada

Disclosure information not submitted.

Presentation(s):

Paper 34 - A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED OSTEOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA

Friday, November 3, 2023
9:00 AM – 10:00 AM